Literature DB >> 10690509

Genetic progression and clonal relationship of recurrent premalignant head and neck lesions.

J Califano1, W H Westra, G Meininger, R Corio, W M Koch, D Sidransky.   

Abstract

We constructed a preliminary genetic progression model for head and neck squamous cell carcinoma (HNSC) based on the frequency of genetic alterations in preneoplastic and neoplastic lesions from single biopsy specimens. To firmly establish the temporal order of established genetic events in HNSC, we sampled serial biopsies from five patients with recurrent premalignant lesions at a single anatomic site over a period of time (1 month to 144 months). These lesions were examined by microsatellite analysis of the minimal regions of loss on the 10 most frequently lost chromosomal arms in HNSC. Each set of serial biopsies from all five patients demonstrated LOH (loss of heterozygosity) of identical alleles at multiple loci with identical boundaries between areas of LOH and retention of heterozygosity, indicating a common clonal origin for each set. Three patients demonstrated genetic progression (new regions of LOH) over time correlating with histopathological progression, one patient demonstrated lack of genetic progression associated with unchanged histopathological morphology, and one patient demonstrated histopathological progression without detection of a corresponding genetic progression event. For one of these patients with a laryngeal tumor, at least four separate steps in progression to malignancy could be determined, accompanied by spatial expansion of an increasingly altered clonal population from the ipsilateral to the contralateral side, ultimately resulting in a malignancy. Microsatellite-based genetic analysis of recurrent premalignant lesions indicates that these lesions arise from a common clonal progenitor, followed by outgrowth of clonal populations associated with progressive genetic alterations and phenotypic progression to malignancy.

Entities:  

Mesh:

Year:  2000        PMID: 10690509

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


  39 in total

Review 1.  Genetic alterations in head and neck cancer: interactions among environmental carcinogens, cell cycle control, and host DNA repair.

Authors:  C Y Fan
Journal:  Curr Oncol Rep       Date:  2001-01       Impact factor: 5.075

2.  The influence of clinical and demographic risk factors on the establishment of head and neck squamous cell carcinoma cell lines.

Authors:  Jason S White; Joel L Weissfeld; Camille C R Ragin; Karen M Rossie; Christa Lese Martin; Michele Shuster; Chandramohan S Ishwad; John C Law; Eugene N Myers; Jonas T Johnson; Susanne M Gollin
Journal:  Oral Oncol       Date:  2006-11-16       Impact factor: 5.337

Review 3.  Molecular mechanisms of head and neck cancer.

Authors:  Amit M Deshpande; David T Wong
Journal:  Expert Rev Anticancer Ther       Date:  2008-05       Impact factor: 4.512

Review 4.  Molecular biology of squamous cell carcinoma of the head and neck.

Authors:  B Perez-Ordoñez; M Beauchemin; R C K Jordan
Journal:  J Clin Pathol       Date:  2006-05       Impact factor: 3.411

5.  Saliva protein biomarkers to detect oral squamous cell carcinoma in a high-risk population in Taiwan.

Authors:  Jau-Song Yu; Yi-Ting Chen; Wei-Fan Chiang; Yung-Chin Hsiao; Lichieh Julie Chu; Lai-Chu See; Chi-Sheng Wu; Hui-Tzu Tu; Hsiao-Wei Chen; Chia-Chun Chen; Wei-Chao Liao; Ya-Ting Chang; Chih-Ching Wu; Che-Yi Lin; Shyun-Yeu Liu; Shu-Ti Chiou; Shu-Li Chia; Kai-Ping Chang; Chih-Yen Chien; Su-Wei Chang; Chee-Jen Chang; John D Young; Chia C Pao; Yu-Sun Chang; Leland H Hartwell
Journal:  Proc Natl Acad Sci U S A       Date:  2016-09-23       Impact factor: 11.205

6.  Epithelial-mesenchymal transition (EMT) markers have prognostic impact in multiple primary oral squamous cell carcinoma.

Authors:  Sabrina Daniela da Silva; Grégoire B Morand; Faisal A Alobaid; Michael P Hier; Alex M Mlynarek; Moulay A Alaoui-Jamali; Luiz Paulo Kowalski
Journal:  Clin Exp Metastasis       Date:  2014-11-30       Impact factor: 5.150

7.  An attenuated adenovirus, ONYX-015, as mouthwash therapy for premalignant oral dysplasia.

Authors:  Charles M Rudin; Ezra E W Cohen; Vassiliki A Papadimitrakopoulou; Sol Silverman; Wendy Recant; Adel K El-Naggar; Kirsten Stenson; Scott M Lippman; Waun Ki Hong; Everett E Vokes
Journal:  J Clin Oncol       Date:  2003-11-03       Impact factor: 44.544

8.  Hyperphosphorylation of replication protein A in cisplatin-resistant and -sensitive head and neck squamous cell carcinoma cell lines.

Authors:  Karoline C Manthey; Jason G Glanzer; Diana D Dimitrova; Greg G Oakley
Journal:  Head Neck       Date:  2010-05       Impact factor: 3.147

9.  Single nucleotide polymorphism-based genome-wide chromosome copy change, loss of heterozygosity, and aneuploidy in Barrett's esophagus neoplastic progression.

Authors:  Xiaohong Li; Patricia C Galipeau; Carissa A Sanchez; Patricia L Blount; Carlo C Maley; Jessica Arnaudo; Daniel A Peiffer; Dmitry Pokholok; Kevin L Gunderson; Brian J Reid
Journal:  Cancer Prev Res (Phila)       Date:  2008-11

Review 10.  Epigenetic alterations in head and neck cancer: prevalence, clinical significance, and implications.

Authors:  Chun-Yang Fan
Journal:  Curr Oncol Rep       Date:  2004-03       Impact factor: 5.075

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.